Revvity, Inc. (NYSE: RVTY) today announced it has entered into a definitive agreement to acquire Human Cell Design (HCD), a France-based biotechnology company specializing in human cell models and ...
Zacks Investment Research on MSN
Revvity to acquire Human Cell Design to boost metabolic discovery
Revvity, Inc. RVTY recently announced that it has entered into a definitive agreement to acquire Human Cell Design (HCD), a ...
For the first time, a stem cell model has produced a structure resembling an early human embryo with a yolk-sac-like structure, from a single starting stem cell population and without direct genetic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results